Brought to you by 
Devax Inc. raises $5.45mm in second round
17 Aug 2001
Executive Summary
Devax Inc. (interventional cardiology devices) grossed $5.45mm in its placement of Series B preferred stock. International Biomedicine Holdings of Basel put in $2.5mm and led a syndicate of US venture firms; Rock Creek Partners and Medfocus Fund were two of the participants.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com